Chesterfield, MO, United States of America

David Louis Brown

This inventor holds 54 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 5143). Top assignees: G.d. Searle & Company, Pharmacia Corporation, Pharmacia & Upjohn Company. Active years: 1997-2016.

USPTO Granted Patents = 54 (Patent Applications = 1)

% Patents Active = 44.4

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 8.2

ph-index = 10

Forward Citations = 474(Granted Patents)

Forward Citations (Not Self Cited) = 425(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Chestefield, MO (US) (2000)
Chesterfield, MO (US) (1997 - 2016)

Company Filing History:

33 out of 1,323

G.d. Searle & Company

patents

11 out of 220

Pharmacia Corporation

patents

3 out of 523

Pharmacia & Upjohn Company

patents

4. 2 out of 202

Elan Pharmaceuticals, Inc.

Monsanto Technology LLC

Pharmacia Corporation (of Pfizer, Inc.)

patents

9. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2016

Loading Chart...

Areas of Expertise:

Oxadiazoles

Retroviral Protease Inhibitors

Benzopyran Compounds

Sulfonamide

Piperidines

Prodrugs

Inflammation

Pyrazoles

Amino Acids

Heterocycles

COX-2 Inhibitors

Peptidomimetics

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9273037 - Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles (2016-03-01),

2. 9040711 - Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles (2015-05-26),

3. 7902195 - Pyridine [3,4-b] pyrazinones (2011-03-08),

4. 7420061 - Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors (2008-09-02),

5. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2008-03-04),

6. 7338965 - 3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines (2008-03-04),

7. 7259266 - Benzopyran compounds useful for treating inflammatory conditions (2007-08-21),

8. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2007-01-09),

9. 7144897 - Hydroxy alkyl amines (2006-12-05),

10. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-11-28),

11. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),

12. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),

13. 7109211 - Substituted benzopyran derivatives for the treatment of inflammation (2006-09-19),

14. 7098202 - Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-08-29),

15. 6998415 - Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors (2006-02-14),

Title: The Inventor David Louis Brown: Pioneering Innovations in Chesterfield

Introduction: David Louis Brown, a distinguished inventor hailing from Chesterfield, MO, has made significant contributions to the world of technology and innovation.

Latest Patents: David Louis Brown's latest patents include groundbreaking inventions in the fields of renewable energy, sustainable agriculture, and advanced robotics.

Career Highlights: Throughout his illustrious career, David Louis Brown has been recognized for his exceptional problem-solving skills and his ability to translate innovative ideas into practical solutions. His work has revolutionized various industries, earning him a reputation as a visionary inventor.

Collaborations: David Louis Brown has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market. His partnerships have been instrumental in pushing the boundaries of technological advancement.

Conclusion: In conclusion, David Louis Brown stands as a beacon of innovation, constantly pushing the envelope of what is possible through his inventive spirit and dedication to creating a better future for all.